Earnings History Data for Alimera Sciences (ALIM) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
See the full list of available companies here.

Alimera Sciences

Alimera Sciences, Inc., based in Alpharetta, Georgia, is a biopharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals. The Company is presently focused on diseases affecting the back of the eye, or retina because it believes these diseases are not well treated with current therapies and represent a significant market opportunity. Its product candidate Iluvien(R) is an intravitreal insert containing fluocinolone acetonide, a non-proprietary corticosteroid with demonstrated efficacy in the treatment of ocular disease. Iluvien is in development for the treatment of diabetic macular edema (DME). DME is a disease of the retina that affects individuals with diabetes and can lead to severe vision loss and blindness.
Release Date Time Est. Time Symbol Name Market Cap (M) Rep. EPS Est. EPS Last years EPS SeekingAlpha Headline Price Change Ext. Hours Price Ext. Hours Change 52 Week Range Volume Avg. Volume Ext. Hours Volume Top Mover
06-08-2024 PM ALIM Alimera Sciences 291.00 -0.06 -0.03 0.00 Alimera Sciences GAAP EPS of -$0.06, revenue of $27M
[8/6/2024 8:53 AM]		 5.54 -0.01 
(-0.18%)		 0.0 0.0 
(0.00%)		 2.61 - 5.65 193,502 500,000 0
14-05-2024 PM ALIM Alimera Sciences, Inc. 186.12 -0.12 -0.04 -0.71 Alimera Sciences GAAP EPS of -$0.12 misses by $0.06, revenue of $23.01M beats by $0.76M
[5/14/2024 7:34 AM]		 3.23 -0.25 
(-7.18%)		 3.39 -0.09 
(-2.59%)		 1.64 - 4.38 147,859 60,000 151
07-03-2024 PM ALIM Alimera Sciences, Inc. 198.14 -0.07 0.02 -0.54 Alimera Sciences GAAP EPS of -$0.07, revenue of $26.31M beats by $1.97M
[3/7/2024 7:38 AM]		 3.90 0.02 
(0.65%)		 3.94 0.07 
(1.81%)		 1.30 - 4.38 41,812 60,000 3,630
26-10-2023 PM ALIM Alimera Sciences, Inc. 27.99 -0.06 -0.41 -0.75 Alimera Sciences GAAP EPS of -$0.06 misses by $0.18, revenue of $23.4M beats by $0.68M
[10/26/2023 7:17 AM]		 3.25 0.12 
(3.83%)		 0.0 0.0 
(0.00%)		 1.30 - 5.61 51,003 40,000 0
10-08-2023 PM ALIM Alimera Sciences, Inc. 22.44 -0.44 0.06 -0.45 Alimera Sciences GAAP EPS of -$1.32 misses by $1.33, revenue of $17.5M misses by $2.95M
[8/10/2023 7:37 AM]		 3.36 0.23 
(7.35%)		 3.25 0.12 
(3.83%)		 1.30 - 7.88 53,794 20,000 850
15-05-2023 PM 7:30 AM ET
(May 15)		 ALIM Alimera Sciences, Inc. 12.13 -0.71 -0.58 -0.85 Alimera Sciences GAAP EPS of -$0.71 misses by $0.19, revenue of $13.55M beats by $1.25M
[5/15/2023 7:54 AM]		 1.64 0.02 
(1.31%)		 0.0 0.0 
(0.00%)		 1.30 - 7.92 7,916 20,000 0
31-03-2023 PM 7:30 AM ET
(Mar 31)		 ALIM Alimera Sciences, Inc. 15.84 -0.54 -0.28 -0.59 Alimera Sciences GAAP EPS of -$0.54 misses by $0.20, revenue of $14.03M misses by $0.59M
[3/31/2023 8:04 AM]		 2.10 0.32 
(17.98%)		 0.0 0.0 
(0.00%)		 1.30 - 7.92 65,269 80,000 0
14-11-2022 PM 7:30 AM ET
(Nov 14)		 ALIM Alimera Sciences, Inc. 33.44 -0.75 -0.37 -0.60 Alimera Sciences GAAP EPS of -$0.75 misses by $0.35, revenue of $13.6M misses by $1.45M
[11/14/2022 7:32 AM]		 4.95 -0.03 
(-0.60%)		 0.0 0.0 
(0.00%)		 3.94 - 7.92 20,452 10,000 0
27-07-2022 PM 8:00 AM ET
(Jul 27)		 ALIM Alimera Sciences, Inc. 37.89 -0.45 -0.61 0.76 Alimera Sciences reports Q2 results
[7/27/2022 5:58 AM]		 5.50 0.35 
(6.80%)		 0.0 0.0 
(0.00%)		 3.94 - 9.79 24,880 10,000 0
09-05-2022 PM 8:00 AM ET
(May 9)		 ALIM Alimera Sciences, Inc. 40.77 -0.85 -0.67 -0.63 Alimera Sciences GAAP EPS of -$0.85 misses by $0.16, revenue of $11.89M misses by $1.01M
[5/9/2022 8:03 AM]		 5.00 -0.45 
(-8.26%)		 0.0 0.0 
(0.00%)		 3.94 - 10.50 155,380 10,000 0
24-02-2022 PM 7:30 AM ET
(Feb 24)		 ALIM Alimera Sciences, Inc. 32.26 -0.59 -0.38 -0.18 Alimera Sciences GAAP EPS of -$0.59 misses by $0.17, revenue of $13.95M beats by $0.55M
[2/24/2022 8:05 AM]		 4.75 0.08 
(1.71%)		 0.0 0.0 
(0.00%)		 0.0 - 0.0 40,483 0 0
28-10-2021 PM 8:00 AM ET
(Oct 28)		 ALIM Alimera Sciences, Inc. 30.47 -0.60 -0.52 -0.12 Alimera Sciences EPS misses by $0.07, misses on revenue
[10/28/2021 8:10 AM]		 4.41 0.10 
(2.32%)		 4.40 0.09 
(2.09%)		 3.82 - 12.25 47,246 60,000 1,801
13-08-2021 PM Before the open
(Aug 13)		 ALIM Alimera Sciences, Inc. 56.15 0.76 1.25 -0.51 Alimera Sciences EPS misses by $0.03, beats on revenue
[8/13/2021 8:13 AM]		 7.19 -1.31 
(-15.41%)		 0.0 0.0 
(0.00%)		 3.82 - 12.25 94,046 0 0
28-04-2021 AH 4:05 PM ET
(Apr 28)		 ALIM Alimera Sciences, Inc. 73.81 -0.63 -0.50 -0.24 Alimera Sciences EPS misses by $0.09, misses on revenue
[4/28/2021 4:38 PM]		 10.26 -1.05 
(-9.28%)		 10.75 -0.56 
(-4.95%)		 3.82 - 12.25 53,387 70,000 476
24-02-2021 AH 4:05 PM ET
(Feb 24)		 ALIM Alimera Sciences, Inc. 52.62 -0.18 -0.09 0.08 Alimera Sciences EPS misses by $0.16, beats on revenue
[2/24/2021 4:15 PM]		 7.76 -1.23 
(-13.68%)		 0.0 0.0 
(0.00%)		 2.86 - 10.79 76,021 113,957 0
28-10-2020 AH 4:05 PM ET
(Oct 28)		 ALIM Alimera Sciences, Inc. 22.26 -0.12 -0.49 -0.60 Alimera Sciences EPS beats by $0.32, beats on revenue
[10/28/2020 4:23 PM]		 4.20 0.0 
(0.00%)		 4.23 0.03 
(0.71%)		 0.0 - 9.98 30,182 16,048 772
29-07-2020 AH 4:00 PM ET
(Jul 29)		 ALIM Alimera Sciences, Inc. 30.29 -0.51 -2.14 -1.05 Alimera Sciences EPS beats by $1.10, beats on revenue
[7/29/2020 4:29 PM]		 6.10 0.04 
(0.74%)		 0.0 0.0 
(0.00%)		 0.0 - 11.85 28,930 18,743 0